The NPR article is keenly addresses the Drug Enforcement Administration’s questionable stance on buprenorphine. The article explores the issue through Martin Njoku’s personal anecdote entailing his experience of the DEA’s raid on his local pharmacy in West Virginia, ultimately resulting in the revocation of his registration to dispense controlled substances. What’s devastating is that the article confronts the existing barriers for addiction treatment as government agencies implement roadblocks founded upon stigma and a lack of understanding for substance use disorders. These roadblocks are affecting pharmacy operations in regards to the dispensation of MAT, such as Suboxone.
To read NPR‘s article click here.
